Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
Kim SI, Szeto AH, Morgan KP, Brower B, Dunn MW, Khandani AH, Godley PA, Rose TL, Basch EM, Milowsky MI, Whang YE, Crona DJ. Kim SI, et al. Among authors: basch em. PLoS One. 2021 Dec 31;16(12):e0262326. doi: 10.1371/journal.pone.0262326. eCollection 2021. PLoS One. 2021. PMID: 34972194 Free PMC article.
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
Kim SI, Szeto AH, Morgan KP, Brower B, Dunn MW, Khandani AH, Godley PA, Rose TL, Basch EM, Milowsky MI, Whang YE, Crona DJ. Kim SI, et al. Among authors: basch em. PLoS One. 2021 Jun 21;16(6):e0253021. doi: 10.1371/journal.pone.0253021. eCollection 2021. PLoS One. 2021. PMID: 34153052 Free PMC article. Clinical Trial.
Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings.
Rose TL, Deal AM, Basch E, Godley PA, Rathmell WK, Kim WY, Whang YE, Dunn MW, Wang A, Chen RC, Nielsen ME, Pruthi RS, Wallen EM, Woods ME, Smith AB, Milowsky MI. Rose TL, et al. Among authors: basch e. Urol Oncol. 2015 Sep;33(9):386.e1-6. doi: 10.1016/j.urolonc.2015.05.028. Epub 2015 Jun 27. Urol Oncol. 2015. PMID: 26122712 Free PMC article.
Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC).
Eulitt PJ, Altun E, Sheikh A, Wong TZ, Woods ME, Rose TL, Wallen EM, Pruthi RS, Smith AB, Nielsen ME, Whang YE, Kim WY, Godley PA, Basch EM, David GU, Ramirez J, Deal AM, Rathmell WK, Chen RC, Bjurlin MA, Lin W, Lee JK, Milowsky MI. Eulitt PJ, et al. Among authors: basch em. Clin Genitourin Cancer. 2020 Oct;18(5):378-386.e1. doi: 10.1016/j.clgc.2020.02.008. Epub 2020 Mar 6. Clin Genitourin Cancer. 2020. PMID: 32147364
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.
Kramer BS, Hagerty KL, Justman S, Somerfield MR, Albertsen PC, Blot WJ, Ballentine Carter H, Costantino JP, Epstein JI, Godley PA, Harris RP, Wilt TJ, Wittes J, Zon R, Schellhammer P; American Society of Clinical Oncology Health Services Committee; American Urological Association Practice Guidelines Committee. Kramer BS, et al. J Clin Oncol. 2009 Mar 20;27(9):1502-16. doi: 10.1200/JCO.2008.16.9599. Epub 2009 Feb 24. J Clin Oncol. 2009. PMID: 19252137 Free PMC article. Review.
Feasibility and delivery of patient-reported outcomes in clinical practice among racially diverse bladder and prostate cancer patients.
Smith AB, Samuel CA, McCabe SD, Deal A, Jonsson M, Mueller DE, Mahbooba ZM, Bennett AV, Chung AE, Nielsen ME, Tan HJ, Wallen E, Pruthi R, Wang A, Basch E, Reeve BB, Chen RC. Smith AB, et al. Urol Oncol. 2021 Jan;39(1):77.e1-77.e8. doi: 10.1016/j.urolonc.2020.06.030. Epub 2020 Aug 17. Urol Oncol. 2021. PMID: 32819814 Free PMC article.
336 results